Tools · BMY
Bristol-Myers Squibb Company, taken apart.
Four panels built from the reported annual accounts, then the rest of the engine. Every figure below is Bristol-Myers Squibb Company’s own filing, not an estimate of ours.
Income statement
Revenue mix
Peer comparison
Analyst ratings
What if I had bought
Sentiment
Chart patterns
What the analysts say
The published view, for contrast with ours. The source gives a consensus and a target range rather than a full buy/hold/sell breakdown, so that is what is shown — and it is why the grade scores analyst upside rather than counting recommendations.
| Published figure | Position | Detail |
|---|---|---|
| Consensus: Buy | 24 analysts | |
| Mean target: $66.21 | 66% of range | |
| High target: $80.00 | 100% of range | |
| Low target: $40.00 | 0% of range |
24 analysts cover it, and their targets run from $40.00 to $80.00 — a spread of 100%, with the mean 2.3% below today's price. A consensus is an average of disagreement, not a forecast.
The rest of the engine
The panels above are built from filings. These run against the live engine.
/screener
Screener
Preset screens run against the live universe
Value, growth, quality and momentum presets
/markets
Markets
Indices, sector performance and the yield curve
One request per panel, cached for ten minutes
/dcf-calculator
DCF calculator
Value the company on the cash it produces
The projection period and terminal growth are yours
/watchlist
Watchlist
Follow symbols with a live price and day change
Needs an account
/portfolio
Portfolio
Holdings with unrealised profit and loss
Totalled per currency — needs an account
/learn
Learn
Guides, a glossary and the assistant
Explains the scorecard this site actually runs